Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
TRYP Therapeutics Inc
C.TRYP
Healthcare
Tryp Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric...
disorders through the dosing of formulations of synthetic psilocybin. The primary indications for its PFN are in the areas of chronic pain, including fibromyalgia, phantom limb pain and complex regional pain syndrome, and eating disorders, including binge eating and hypothalamic obesity. The Company's product pipeline includes TRP-8802 and TRP-8803. TRP-8803 uses a formulation and route of administration to improve the patient experience.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:TRYP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(1930)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jul 13, 2023 6:58am
Tryp Therapeutics Receives Confirmation From FDA To Proceed
KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on
...more
(4)
•••
Blackpenny
X
View Profile
View Bullboard History
Post by
Blackpenny
on Sep 06, 2022 10:59pm
Making money else where!
Sold off half to free up cash not doing any thing in all most 2 years.
Lancaster Resources Receives BLM Drilling Approval for Alkali Flat Lithium Brine Project
posted May 15, 2024 9:00am by
Lancaster Resources Inc.
-
|
"The BLM approval of our Plan of Operations application is further proof of Lancasters’ vision of providing sustainable and minimal impact critical minerals for the energy transition,” says Andrew Watson, Lancaster's VP Engineering & Operations. "We are rapidly progressing to drilling our maiden exploration well at Alkali Flat and showing the significant potential lithium brine deposit in the ...read more
(17)
•••
FastFF
X
View Profile
View Bullboard History
Post by
FastFF
on Feb 28, 2022 2:38pm
Well, I'm impressed
Somebody has a working brain. Changed the financing - now no warrants + a fat premium to "market" makes TRYP look super attractive. They have several drugs in phase 2. The other ones that
...more
(17)
•••
FastFF
X
View Profile
View Bullboard History
Post by
FastFF
on Feb 04, 2022 3:33pm
Lovely - free warrant for the VC
And he just fired the management team. Chart looks like a ski slope.....all downhill
(50)
•••
lithiums
X
View Profile
View Bullboard History
Post by
lithiums
on Feb 04, 2022 8:58am
Halt trading
Tryp Therapeutics halted at open 2022-02-04 08:36 ET - Halt Trading Tryp Therapeutics Inc. has been halted at the open on Feb. 4, 2022.
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Nov 18, 2021 9:22pm
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Nov 17, 2021 10:13am
🎉📣FSD Pharma's Research and Clinical Advisory Board📢
Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical Advisory Board. FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA
...more
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Nov 10, 2021 2:27am
📣FSD Pharma:Agreement Signed With Covar Pharmaceuticals📢📣
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Oct 30, 2021 10:39am
📢📣FSD Pharma forms agreement with Covar Pharmaceuticals 📢
(1930)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Oct 07, 2021 7:23am
Collaboration with Researchers
Tryp has partnered with Paul Hutson, PharmD and Christopher Nicholas, PhD to advance the Company's proprietary, psilocybin-based drug product San Diego, California--(Newsfile Corp. - October 7
...more
(1930)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 10, 2021 7:07am
Partners with Calvert Labs
Tryp has also entered into an agreement with Gad Consulting Services to collaborate on the preclinical studies San Diego, California--(Newsfile Corp. - August 10, 2021) - Tryp Therapeutics
...more
(127)
•••
SkywalkerofLuke
X
View Profile
View Bullboard History
Post by
SkywalkerofLuke
on Jul 26, 2021 6:22pm
Video on $TRYP
Been bullish on $TRYP for a while now with the cannabis/psychedelics market starting to go mainstream, and now they're currently working towards getting their psilocybin treatment FDA approved
...more
(46)
•••
maysilverstone
X
View Profile
View Bullboard History
Post by
maysilverstone
on Jul 23, 2021 12:20pm
$TRYP- Psychedelic stock to watch
They are working to get their psilocybin treatments approved by the FDA and on the market. By targeting the 505 b2 and the orphan drug design, $TRYP is granted the "
...more
(12)
•••
Snyderman88
X
View Profile
View Bullboard History
Post by
Snyderman88
on Jul 22, 2021 1:10pm
Tryp Therapeutics, my psychedelic sectors buy low option
As I continue my dive in to psychedelic treatments, Tryp Therapeutics has jumped out at me. Tryp Therapeutics (Ticker: TRYP.c TRYPF) is a San Diego-based pharmaceutical
...more
(75)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Jul 21, 2021 3:13pm
Great news for Tryp
Tryp Therapeutics ( $TRYP ) has begun phase 2 trials of their TRYP-8802 oral formulation with the University of Michigan. TRYP-8802 is synthetic psilocybin Tryp and UoM are testing the
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
IAMGOLD Reports First Quarter 2024 Results
Drilling Approval Received for New Mexico Lithium Project